Table 2: Significant p values from two-way ANOVA (genotype x treatment) for male P30 CX-4945-treated Ts65Dn trabecular and cortical parameters and body weight.
BMD | BV/TV | Tb.Th | Tb.Spǂ | Tb.N | Average Weight | Weight Gain | |||
---|---|---|---|---|---|---|---|---|---|
Genotype Effect | 0.008 | 0.008 | NS | 0.008 | 0.008 | <0.001 | NS | ||
Treatment Effect | NS | NS | NS | NS | NS | NS | NS | ||
Interaction | NS | NS | NS | NS | NS | NS | NS | ||
Tt.Ar | Ma.Ar | Ct.Ar | Ct.Th | Ps.Pm | Ec.Pm | Imax | Imin | Ct.TMD | |
Genotype Effect | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
Treatment Effect | NS | NS | NS | NS | NS | NS | NS | NS | NS |
Interaction | NS | NS | NS | NS | NS | NS | NS | NS | NS |
indicates the data was log-transformed for statistical analysis due to non-normal distribution. NS indicates p value was not significant. Vehicle-treated euploid (n = 10), CX-4945-treated euploid (n = 13), vehicle-treated Ts65Dn (n = 13), CX-4945-treated Ts65Dn (n = 8).